The Department of War has announced a new change to its drug screening policy that will directly affect all service members.

According to an Aug. 18 memo, the Pentagon will begin testing troops for psilocin, the substance that signals the use of psilocybin mushrooms.

The update marks a clear shift in how the military addresses drug use, and the change will go into effect on Oct. 1.

The memo states that psilocin is being added to drug testing panels “due to the risk of impairment and subsequent deterioration of security, military fitness, readiness, good order and discipline.”

Here's What They're Not Telling You About Your Retirement

This language highlights the Pentagon’s concern that psychedelic substances could undermine the ability of troops to perform their duties. Because military readiness depends on alertness, stability, and discipline, leaders are taking steps to address substances that could create unpredictable behavior.

Psilocybin mushrooms, often called magic mushrooms, are known for their hallucinogenic effects. After consumption, psilocybin is metabolized into psilocin, which is the active compound that produces altered perception, hallucinations, and shifts in mood.

According to the Drug Enforcement Administration, high doses can lead to vomiting, disorientation, and even psychotic episodes.

Therefore, while some individuals outside the military have advocated for research into potential therapeutic uses, the Pentagon is focusing on the risks these substances pose to service members who must remain mission ready.

This Could Be the Most Important Video Gun Owners Watch All Year

The inclusion of psilocybin mushrooms in the military’s screening process reflects a broader push to toughen drug testing policies.

The Pentagon is not only adding substances to its panels but also revamping the entire system.

This includes giving commanders more flexibility in requesting drug screenings, modernizing administrative processes, and commissioning studies to better understand patterns of drug abuse within the ranks.

At the same time, these changes signal a clear intent to keep pace with shifting drug trends in civilian society, where discussions about psychedelics are becoming more common.

Both psilocybin and psilocin are listed by the DEA as Schedule I controlled substances.

This means that the federal government has determined they have no currently accepted medical use, carry a high potential for abuse, and cannot be used safely under medical supervision.

By aligning its policy with these standards, the Pentagon is ensuring consistency between civilian law and military regulations.

Because the military must uphold strict standards of order and discipline, it cannot afford to allow service members to experiment with substances that are unpredictable and illegal.

The timing of this change is notable. Across the country, several states and cities have begun debating or even implementing measures to decriminalize or regulate psychedelic substances.

Advocates argue that psilocybin may have benefits in treating depression, anxiety, and post-traumatic stress disorder.

However, until the Food and Drug Administration approves such uses, the federal government continues to classify these mushrooms as unsafe and unlawful.

For the Pentagon, which operates under federal law, the priority remains ensuring that troops are not impaired in ways that compromise national security.

The move also speaks to the broader balancing act the military must maintain.

On one hand, it recognizes that some of its personnel may be aware of or influenced by evolving attitudes in the civilian world toward substances like marijuana and psychedelics.

On the other hand, it must enforce a standard that guarantees readiness and safety in the field. By taking this step, defense leaders are making it clear that military service requires a higher threshold of accountability.

The Pentagon’s memo leaves little room for interpretation.

Starting Oct. 1, testing for psilocin will be standard across the force. Those found in violation could face disciplinary action, including administrative separation or other consequences under the Uniform Code of Military Justice.

The message is unmistakable: psychedelic substances, regardless of how they are being discussed in civilian society, have no place in the armed forces.

In conclusion, the Pentagon’s decision to expand drug testing to include psilocybin mushrooms is rooted in a commitment to security, readiness, and discipline. Because the military relies on trust and reliability at every level, leadership views the risks associated with hallucinogens as unacceptable.

As the national conversation around psychedelics continues, the armed forces are sending a firm signal that their standards will remain aligned with the law and with the fundamental requirements of military service.

Warning: Account balances and purchasing power no longer tell the same story. Know in 2 minutes if your retirement is working for you.